Aclaris Therapeutics Inc Sustainability Reports
Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases. The company primarily utilizes a robust research and development engine to explore protein kinase regulation.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 5493000B2LQ9QTW1DF52
FIGI: BBG003LF0QS8
1 reports from 2024 to 2024
